Page 492 - Clinical Application of Mechanical Ventilation

458 Chapter 13

Hinkle, J. R. (2011). NDA 21-912 Brovana Inhalation Solution Risk Evaluation and Mitigation Strategy
(REMS). http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor
PatientsandProviders/UCM245182.pdf. Accessed May 2, 2011.

Honey, B., Harrison, D. L., Gormley, A. K., & Johnson, P. N. (2010). Evaluation of adverse events noted in chil-
dren receiving continuous infusions of dexmedetomidine in the intensive care unit. Journal of Pediatric Phar-
macology &Therapeutics, 15(1): 30–37.
Jacox, A., Carr, D. B., Payne, R., Berde, C. B., Breitbart, W., Cain, J. M., . . . Weissman, D. E. (1994, March).
Management of cancer pain. Clinical Practice Guideline No. 9 AHCPR Publication No. 94-0592. Rockville,
MD. Agency for Health Care Policy and Research, U. S. Department of Health and Human Services, Public
Health Service.
Kee, J. L. (2005). Laboratory and diagnostic tests with nursing implications (7th ed.). Englewood Cliffs, NJ: Prentice-Hall.

Kinsella, J. P., & Abman, S. H. (1999). Recent developments in inhaled nitric oxide therapy of the newborn.
Current Opinionin Pediatrics, 11(2), 121–125.
Kupfer, Y., Okren, D. G., Twersky, R. A., & Tessler, S. (1987). Disuse atrophy in a ventilated patient with status
asthmaticus receiving neuromuscular blockade. Critical Care Medicine, 15(8), 795–799.
Levine, R. L. (1994). Pharmacology of intravenous sedatives and opioids in critically ill patients. Critical Care
Clinics, 10, 709–731.
Lindberg, L., & Rydgren, G. (1999). Production of nitrogen dioxide during nitric oxide therapy using the Servo
Ventilator 300 during volume-controlled ventilation. Acta Anaesthesiologica Scandinavica, 43(3), 289–294.
Lunn, R. J. (1995). Inhaled nitric oxide therapy. Mayo Clinic Proceedings, 70(3), 247–255.
Marik, P., Hogan, J., & Krikorian, J. (1999). A comparison of bronchodilator therapy delivered by nebulization
and meter-dose inhaler in mechanically ventilated patients. CHEST Journal, 115(6), 1653–1657.
McCartney, J. R., & Boland, R. J. (1993). Understanding and managing behavioral disturbances in the ICU.
Journal of Critical Illness, 87–97.
McCartney, J. R., & Boland, R. J. (1994). Anxiety and delirium in the intensive care unit. Critical Care Clinics,
10, 673–680.
McEvoy, G. K. (Ed.). (1995). AHFS drug information. Bethesda, MD: American Society of Health System
Pharmacists.
Mirenda, J., & Broyles, G. (1995). Propofol as used for sedation in the ICU. CHEST Journal, 108, 539–548.
Mohler, H., & Okada, T. (1977). Demonstration of benzodiazepine receptors in the central nervous system.
Science, 198, 849–851.
Mohler, H., & Richards, J. G. (1988). The benzodiazepine receptor: A pharmacological control element of brain
function. European Journal of Anaesthesiology, (Suppl. 2), 15–24.
Mouloudi, E., Katsanoulas, K., Anastasaki, M., Askitopoulou, E., & Georgopoulos, D. (1998). Bronchodila-
tor delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of end-inspiratory
pause. European Respiratory Journal, 12(1), 165–169.
NIH Publication No. 97-4051. (1997). U.S. Department of Health and Human Services, National Asthma Edu-
cation and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma.
Ochikubo, C. G., Waffarn, F., & Turbow, R., & Kanakriyeh, M. (1997). Echocardiographic evidence of im-
proved hemodynamics during inhaled nitric oxide therapy for persistent pulmonary hypertension of the new-
born. Pediatric Cardiolology, 18(4), 282–287.

Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.